By Dan Darrow

October 20, 2022

Intraday Update: MDGL

Today is the decision day for the MDGL Nov18 strangle, and after monitoring the options for a couple of weeks, we are going to need to walk away from the trade idea. The option pricing is not lining up for a quality risk/reward setup, and opening a higher-risk position with a subpar risk/reward does not make sense. It's frustrating to not participate on this catalyst, but there will be other Biotech data events to play.

Open Positions

* The following Open Positions pertain to the Options In Play trade ideas from this and previous editions. Disclosure of the Trader Co-Author’s actual portfolio holdings, as of the date of each publication, is made below under "Trader Author Portfolio Holdings.".

Trader Author Portfolio Holdings

**As of the date and time of publication